Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 3227
Selected: 0
NCT IDTitle
NCT03586661Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT07428486A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia
NCT04127721Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation
NCT02228525Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Myelodysplastic Syndromes
NCT02530476Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia
NCT01504789Part II: Exercise in Hispanic Breast Cancer Survivors
NCT06940518Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
NCT00455559Ph II Study of Perifosine Plus Gleevec for Patients With GIST
NCT00798746Quality of Life After Esophagectomy for Cancer
NCT07318389ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
NCT02876510ACTolog in Patients With Solid Cancers
NCT03430882Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid Tumors
NCT07316010Phase 2 Trial of Lisocabtagene Maraleucel for Minimal Residual Disease in Patients With Large B-cell Lymphoma
NCT05137262A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder
NCT03448003Comprehensive Lifestyle Change To Prevent Breast Cancer
NCT00385788Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
NCT02292485PCORI-CER-1306-03385 Lung Cancer Screening Readiness Study
NCT005046606-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients
NCT04228042Infigratinib Before Surgery for the Treatment of Upper Tract Urothelial Cancer
NCT03283046Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma
NCT00504582Fibrin Melanoma Axillary Node Study in Patients With Melanoma
NCT00787527SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma
NCT01266070TKI 258 in Von Hippel-Lindau Syndrome (VHL)
NCT01392183Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
NCT03390283A Survey of Parent/Caregiver Practices on the Storage, Use, and Disposal of Opioids in a Comprehensive Cancer Center
NCT05672459A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors
NCT01816659An Open-Labeled Pilot Study of Biomarker Response Following Short-Term Exposure to Metformin
NCT02079662The Role of Lifestyle Factors in Breast Cancer-Related Outcomes
NCT02754856Tremelimumab and Durvalumab in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery
NCT01490060Fosaprepitant in Patients Receiving Ifosfamide-based Regimen
NCT00940342Rituximab Plus Sargramostim (GM-CSF) In Patients With Chronic Lymphocytic Leukemia
NCT01421173Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies
NCT03668769Quitting Schedule Mobile Smartphone Application in Helping Participants to Quit Smoking
NCT02151032Using Multimedia Approaches to Communicate Probabilities in Patient Decision Aids for Low-Literacy Populations: Randomized Trial
NCT02971748Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy
NCT03491176Magnetic Resonance (MR) Imaging & Blood Biomarkers for Head and Neck Cancer
NCT00505739Mifepristone for Patients With Endometrial Cancer and LGESS
NCT04090619Frequency of Cachexia in Ambulatory Cancer Patients and Psychological Burden in Patients and Their Primary Caregivers
NCT05048212A Phase II Study of Nivolumab With Ipilimumab and Cabozantinib in Patients With Untreated Renal Cell Carcinoma Brain Metastases
NCT06708949A Randomized Phase 2 Trial of Nivolumab, Relatlimab Plus Ipilimumab vs. Nivolumab Plus Ipilimumab in First-line Advanced Renal Cell Carcinoma (RCC)
NCT02983578Danvatirsen and Durvalumab in Treating Patients With Advanced and Refractory Pancreatic, Non-Small Cell Lung Cancer, and Mismatch Repair Deficient Colorectal Cancer
NCT06656715Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure
NCT02459964Compare Fentanyl Nasal Spray With Intravenous Opioids to Treat Severe Pain
NCT00116363Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma
NCT03219047Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma
NCT00734526Phase I Portion of Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
NCT04580836MRI-Guided Radiation Therapy for the Treatment of Early-Stage Kidney Cancer, the MRI-MARK Trial
NCT00418899Gliogene: Brain Tumor Linkage Study
NCT00386906Sentinel Lymph Node (SLN) Biopsy for Conjunctival/Eyelid Melanoma
NCT04752163DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia